In certain types of NSCLC, the EGFR gene is mutated and becomes constitutively active (i.e., exon 19 deletion or L858R mutation), leading to “addictive” oncogenic signaling (3). This evidence concerns the gene EGFR and non-small cell lung carcinoma.